[CAS NO. 2559703-06-7]  Apostatin-1

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [2559703-06-7]

Catalog
HY-134050
Brand
MCE
CAS
2559703-06-7

DESCRIPTION [2559703-06-7]

Overview

MDL-
Molecular Weight345.50
Molecular FormulaC19H27N3OS
SMILESO=C(NC1CCCCCC1)C(SC2=NCCN2C)C3=CC=CC=C3

For research use only. We do not sell to patients.

Summary

Apostatin-1 (Apt-1) is a potent TRADD inhibitor. Apostatin-1 can bind with TRADD-N ( K D =2.17 μM), disrupting its binding to both TRADD-C and TRAF2. Apostatin-1 modulates the ubiquitination of RIPK1 and beclin 1 . Apostatin-1 blocks apoptosis and restores cellular homeostasis by activating autophagy in cells with accumulated mutant tau, α-synuclein , or huntingtin [1] .


In Vitro

Apostatin-1 inhibits Velcade ( Bortezomib , HY-134050)-induced apoptosis and RIPK1-dependent apoptosis (RDA) and necroptosis, with an IC 50 of 0.97 μM [1] .
Apostatin-1 (10 μM, 6 h) effectively induces autophagy and the degradation of long-lived proteins [1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis [1]

Cell Line: SH-SY5Y, HeLa, HT-29, and Jurkat cells
Concentration: 10 μM
Incubation Time: 6 h
Result: Effectively induced autophagy by LC3 II induction and p62 reduction.

In Vivo

Apostatin-1 (20 mg/kg, IP, once) inhibits inflammatory responses, and increases survival of systemic inflammation mouse model [1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Wild-type mice (n = 10, male, 8 weeks of age, systemic inflammation mouse model) [1]
Dosage: 20 mg/kg
Administration: IP, once
Result: Reduced expression of the TNF-induced inflammatory target gene products, NOS and COXII27, and of inflammatory cytokines in cells stimulated with pathogen-associated molecular patterns, including interferon γ (IFNγ), lipopolysaccharide (LPS), Pam3CSK4 (a synthetic bacterial lipopeptide), and muramyl dipeptide (MDP). Showed increased survival following intravenous delivery of TNF, a mouse model of systemic inflammation.

Appearance

Solid


Shipping

Room temperature in continental US; may vary elsewhere.


Storage

Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month

Solvent & Solubility

In Vitro:

DMSO : 83.33 mg/mL ( 241.19 mM ; ultrasonic and warming and adjust pH to 4 with HCl and heat to 80°C)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 2.8944 mL 14.4718 mL 28.9436 mL
5 mM 0.5789 mL 2.8944 mL 5.7887 mL
10 mM 0.2894 mL 1.4472 mL 2.8944 mL
* Please refer to the solubility information to select the appropriate solvent.